Alberti, A.; Lorini, L.; Ravanelli, M.; Perri, F.; Vinches, M.; Rondi, P.; Romani, C.; Bossi, P.
New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma. Vaccines 2022, 10, 885.
https://doi.org/10.3390/vaccines10060885
AMA Style
Alberti A, Lorini L, Ravanelli M, Perri F, Vinches M, Rondi P, Romani C, Bossi P.
New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma. Vaccines. 2022; 10(6):885.
https://doi.org/10.3390/vaccines10060885
Chicago/Turabian Style
Alberti, Andrea, Luigi Lorini, Marco Ravanelli, Francesco Perri, Marie Vinches, Paolo Rondi, Chiara Romani, and Paolo Bossi.
2022. "New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma" Vaccines 10, no. 6: 885.
https://doi.org/10.3390/vaccines10060885
APA Style
Alberti, A., Lorini, L., Ravanelli, M., Perri, F., Vinches, M., Rondi, P., Romani, C., & Bossi, P.
(2022). New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma. Vaccines, 10(6), 885.
https://doi.org/10.3390/vaccines10060885